129 related articles for article (PubMed ID: 10805346)
1. Association of primary central nervous system lymphoma with long-term azathioprine therapy for myasthenia gravis?
Herrlinger U; Weller M; Dichgans J; Melms A
Ann Neurol; 2000 May; 47(5):682-3. PubMed ID: 10805346
[No Abstract] [Full Text] [Related]
2. [Hypersensitivity to azathioprine can simulate an aggravation of myasthenia].
Chevrel G; Moreau T; Vial T; Payen C; Confavreux C
Therapie; 1998; 53(1):77-8. PubMed ID: 9773103
[No Abstract] [Full Text] [Related]
3. Risk of malignancy in myasthenia gravis patients exposed to azathioprine therapy for a median period of 3 years.
Rawoot A; Little F; Heckmann JM
S Afr Med J; 2006 Dec; 96(12):1249-51. PubMed ID: 17252153
[No Abstract] [Full Text] [Related]
4. Cancer occurrence following azathioprine treatment in myasthenia gravis patients: A systematic review and meta-analysis.
Zhang Z; Wang M; Xu L; Jiang B; Jin T; Shi T; Xu B
J Clin Neurosci; 2021 Jun; 88():70-74. PubMed ID: 33992207
[TBL] [Abstract][Full Text] [Related]
5. [Myasthenia gravis. Opportunistic cytomegalovirus infection after long-term azathioprine therapy].
Eisensehr I; Büttner U; Witt TN; von Appen K; Spuler S
Nervenarzt; 1999 Oct; 70(10):924-6. PubMed ID: 10554786
[TBL] [Abstract][Full Text] [Related]
6. Low-dose azathioprine effectively suppresses clinical and immunological manifestations of generalized myasthenia.
Finsterer J; Frank M; Krexner E
South Med J; 2010 Feb; 103(2):182-4. PubMed ID: 20065912
[No Abstract] [Full Text] [Related]
7. Primary CNS lymphoma in myasthenic on long-term azathioprine.
Finelli PF
J Neurooncol; 2005 Aug; 74(1):91-2. PubMed ID: 16078114
[No Abstract] [Full Text] [Related]
8. Neutrophilic dermatosis caused by azathioprine hypersensitivity.
Hurtado-Garcia R; Escribano-Stablé JC; Pascual Jc; Devesa P; Matarredona J; Hurtado-Garcia R
Int J Dermatol; 2012 Dec; 51(12):1522-5. PubMed ID: 22471306
[No Abstract] [Full Text] [Related]
9. Risk of non-melanoma skin cancer in myasthenia patients treated with azathioprine.
Pedersen EG; Pottegård A; Hallas J; Friis S; Hansen K; Jensen PE; Gaist D
Eur J Neurol; 2014 Mar; 21(3):454-8. PubMed ID: 24330255
[TBL] [Abstract][Full Text] [Related]
10. Azathioprine toxicity during long-term immunosuppression of generalized myasthenia gravis.
Hohlfeld R; Michels M; Heininger K; Besinger U; Toyka KV
Neurology; 1988 Feb; 38(2):258-61. PubMed ID: 3340289
[TBL] [Abstract][Full Text] [Related]
11. [Comments on the indication of immunosuppressive long-term therapy in myasthenia gravis (author's transl)].
Fasshauer K; Rath I
Fortschr Neurol Psychiatr; 1981 Mar; 49(3):109-12. PubMed ID: 7227961
[No Abstract] [Full Text] [Related]
12. Safety of long-term combined immunosuppressive treatment in myasthenia gravis--analysis of adverse effects of 163 patients.
Rozsa C; Lovas G; Fornadi L; Szabo G; Komoly S
Eur J Neurol; 2006 Sep; 13(9):947-52. PubMed ID: 16930359
[TBL] [Abstract][Full Text] [Related]
13. Prostatic involvement of a testicular lymphoma in a patient with myasthenia gravis on long-term azathioprine.
Barthelmes L; Thomas KJ; Seale JR
Leuk Lymphoma; 2002 Dec; 43(12):2425-6. PubMed ID: 12613537
[TBL] [Abstract][Full Text] [Related]
14. Primary central nervous system lymphomatoid granulomatosis in a patient receiving azathioprine therapy.
Katherine Martin L; Porcu P; Baiocchi RA; Erter JW; Chaudhury AR
Clin Adv Hematol Oncol; 2009 Jan; 7(1):65-8. PubMed ID: 19274043
[No Abstract] [Full Text] [Related]
15. Cytomegalovirus-associated hemophagocytic lymphohistiocytosis in a patient with myasthenia gravis treated with azathioprine.
Frederiksen JK; Ross CW
Blood; 2014 Apr; 123(15):2290. PubMed ID: 24895699
[No Abstract] [Full Text] [Related]
16. Azathioprine experience in severe, generalized, recalcitrant myasthenia gravis.
Kornfeld P; Ambinder EP; Matta R; Bender A; Papatestas AE; Gross H; Genkins G
Mt Sinai J Med; 1985 May; 52(5):347-52. PubMed ID: 3874354
[No Abstract] [Full Text] [Related]
17. Randomized trial of azathioprine or prednisone for initial immunosuppressive treatment of myasthenia gravis.
Bromberg MB; Wald JJ; Forshew DA; Feldman EL; Albers JW
J Neurol Sci; 1997 Sep; 150(1):59-62. PubMed ID: 9260858
[TBL] [Abstract][Full Text] [Related]
18. A Review of Azathioprine-Associated Hepatotoxicity and Myelosuppression in Myasthenia Gravis.
Jack KL; Koopman WJ; Hulley D; Nicolle MW
J Clin Neuromuscul Dis; 2016 Sep; 18(1):12-20. PubMed ID: 27552384
[TBL] [Abstract][Full Text] [Related]
19. [Eruptive melanocytic nevi during azathioprine therapy in myasthenia gravis].
Braun SA; Helbig D; Frank J; Hanneken S
Hautarzt; 2012 Oct; 63(10):756-9. PubMed ID: 23008007
[TBL] [Abstract][Full Text] [Related]
20. Bone density in myasthenia gravis patients receiving long-term prednisolone therapy.
Wakata N; Nemoto H; Sugimoto H; Nomoto N; Konno S; Hayashi N; Araki Y; Nakazato A
Clin Neurol Neurosurg; 2004 Mar; 106(2):139-41. PubMed ID: 15003307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
